Literature DB >> 11587187

Improved preparation of amyloid-beta peptides using DBU as Nalpha-Fmoc deprotection reagent.

A K Tickler1, C J Barrow, J D Wade.   

Abstract

Previous studies have shown the amyloid peptides, Abeta 1-40/42, to be exceptionally difficult to assemble by Fmoc-solid phase peptide synthesis due to the high hydrophobicity of the C-terminal segment and resulting on-resin aggregation. We found that the use of the stronger and more efficient base, DBU, at a concentration of 2% in DMF for Nalpha-Fmoc deprotection allowed substantially improved continuous flow solid phase assembly of the model peptide Abeta 29-40/42 fragments. This suggested that, at least for these sequences, incomplete deprotection was a greater problem than incomplete amino acid acylation. This base was then used during the synthesis of both Abeta 1-40 and Abeta 1-42, up to and including Ser8, from which point 20% piperidine in DMF was utilized so as to avoid potential aspartimide formation at Asp7. By this means, the deprotection efficiency through the difficult C-terminal portion of the sequence was much improved and resulted in increased availability of terminal amino groups for acylation. This simple strategy that obviates the need for special conditions significantly improved crude peptide quality and allowed considerable facilitation of subsequent purification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587187     DOI: 10.1002/psc.342

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  13 in total

1.  Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

Authors:  Victor L Villemagne; Keyla A Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Revealing protein structures in solid-phase peptide synthesis by 13C solid-state NMR: evidence of excessive misfolding for Alzheimer's β.

Authors:  Songlin Wang; Yoshitaka Ishii
Journal:  J Am Chem Soc       Date:  2012-01-31       Impact factor: 15.419

Review 3.  Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

Authors:  F Rahimi; A Shanmugam; G Bitan
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

4.  Improved chemical synthesis of hydrophobic Aβ peptides using addition of C-terminal lysines later removed by carboxypeptidase B.

Authors:  Saketh Chemuru; Ravindra Kodali; Ronald Wetzel
Journal:  Biopolymers       Date:  2014-03       Impact factor: 2.505

5.  Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide.

Authors:  Ernesto E Ambroggio; Dennis H Kim; Frances Separovic; Colin J Barrow; Kevin J Barnham; Luis A Bagatolli; Gerardo D Fidelio
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

6.  A facile method for expression and purification of (15)N isotope-labeled human Alzheimer's β-amyloid peptides from E. coli for NMR-based structural analysis.

Authors:  Sudhir C Sharma; Tara Armand; K Aurelia Ball; Anna Chen; Jeffrey G Pelton; David E Wemmer; Teresa Head-Gordon
Journal:  Protein Expr Purif       Date:  2015-07-29       Impact factor: 1.650

7.  Fibrillar beta-amyloid peptide Abeta1-40 activates microglial proliferation via stimulating TNF-alpha release and H2O2 derived from NADPH oxidase: a cell culture study.

Authors:  Aiste Jekabsone; Palwinder K Mander; Anna Tickler; Martyn Sharpe; Guy C Brown
Journal:  J Neuroinflammation       Date:  2006-09-07       Impact factor: 8.322

8.  Development of the schedule for multiple parallel "difficult" Peptide synthesis on pins.

Authors:  Ekaterina F Kolesanova; Maxim A Sanzhakov; Oleg N Kharybin
Journal:  Int J Pept       Date:  2013-08-20

9.  Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5).

Authors:  Mohammed Akhter Hossain; Ross A D Bathgate; Chze K Kong; Fazel Shabanpoor; Suode Zhang; Linda M Haugaard-Jönsson; K Johan Rosengren; Geoffrey W Tregear; John D Wade
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

10.  A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide.

Authors:  Dominic M Walsh; Eva Thulin; Aedín M Minogue; Niklas Gustavsson; Eric Pang; David B Teplow; Sara Linse
Journal:  FEBS J       Date:  2009-03       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.